These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 33766984)

  • 41. [Atypical epithelioid hemangioendothelioma: a clinicopathological analysis of eight cases].
    Gong QX; Fan QH; Ding Y; Xiao QX; Wang QY; Tang JL; Song QY; Wang B
    Zhonghua Bing Li Xue Za Zhi; 2019 Aug; 48(8):620-625. PubMed ID: 31422593
    [No Abstract]   [Full Text] [Related]  

  • 42. Epithelioid hemangioma of bone and soft tissue: a reappraisal of a controversial entity.
    Errani C; Zhang L; Panicek DM; Healey JH; Antonescu CR
    Clin Orthop Relat Res; 2012 May; 470(5):1498-506. PubMed ID: 21948309
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Epithelioid hemangioendothelioma].
    Cousin S; Le Loarer F; Crombé A; Karanian M; Minard-Colin V; Penel N
    Bull Cancer; 2019 Jan; 106(1):73-83. PubMed ID: 30527817
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CAMTA1 immunostaining is not useful in differentiating epithelioid hemangioendothelioma from its potential mimickers.
    Yusıflı Z; Kösemehmetoğlu K
    Turk Patoloji Derg; 2014; 30(3):159-65. PubMed ID: 25110239
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A Matched Molecular and Clinical Analysis of the Epithelioid Haemangioendothelioma Cohort in the Stafford Fox Rare Cancer Program and Contextual Literature Review.
    Abdelmogod A; Papadopoulos L; Riordan S; Wong M; Weltman M; Lim R; McEvoy C; Fellowes A; Fox S; Bedő J; Penington J; Pham K; Hofmann O; Vissers JHA; Grimmond S; Ratnayake G; Christie M; Mitchell C; Murray WK; McClymont K; Luk P; Papenfuss AT; Kee D; Scott CL; Goldstein D; Barker HE
    Cancers (Basel); 2023 Sep; 15(17):. PubMed ID: 37686662
    [TBL] [Abstract][Full Text] [Related]  

  • 46. TFE3-rearranged hepatic epithelioid hemangioendothelioma-a case report with immunohistochemical and molecular study.
    Kuo FY; Huang HY; Chen CL; Eng HL; Huang CC
    APMIS; 2017 Sep; 125(9):849-853. PubMed ID: 28585251
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cytologic features of hepatic YAP1-TFE3 rearranged epithelioid hemangioendothelioma.
    Bourgeau M; Martinez A; Deeb KK; Reid MD; Lewis M; Point du Jour KS; Lai J; Shi Q
    Diagn Cytopathol; 2021 Dec; 49(12):E447-E452. PubMed ID: 34411462
    [TBL] [Abstract][Full Text] [Related]  

  • 48. TFE3 rearranged epithelioid hemangioendothelioma of bone: A clinicopathological, immunohistochemical and molecular study of two cases.
    Zhang HZ; Dong L; Wang SY; Yang XQ
    Ann Diagn Pathol; 2020 Jun; 46():151487. PubMed ID: 32151991
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Epithelioid hemangioendothelioma with TFE3 translocation in soft tissue:a clinicopathological study].
    Song QY; Zhu XM; Song GX; Li X; Fan QH; Zhang ZH; Gong QX
    Zhonghua Bing Li Xue Za Zhi; 2021 Oct; 50(10):1151-1156. PubMed ID: 34619869
    [No Abstract]   [Full Text] [Related]  

  • 50. Diagnostic utility of FOSB immunohistochemistry in pseudomyogenic hemangioendothelioma and its histological mimics.
    Sugita S; Hirano H; Kikuchi N; Kubo T; Asanuma H; Aoyama T; Emori M; Hasegawa T
    Diagn Pathol; 2016 Aug; 11(1):75. PubMed ID: 27515856
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Hippo effector TAZ (WWTR1) transforms myoblasts and TAZ abundance is associated with reduced survival in embryonal rhabdomyosarcoma.
    Mohamed A; Sun C; De Mello V; Selfe J; Missiaglia E; Shipley J; Murray GI; Zammit PS; Wackerhage H
    J Pathol; 2016 Sep; 240(1):3-14. PubMed ID: 27184927
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinicopathologic Characterization of Epithelioid Hemangioendothelioma in a Series of 62 Cases: A Proposal of Risk Stratification and Identification of a Synaptophysin-positive Aggressive Subset.
    Shibayama T; Makise N; Motoi T; Mori T; Hiraoka N; Yonemori K; Watanabe SI; Esaki M; Morizane C; Okuma T; Kawai A; Ushiku T; Yatabe Y; Yoshida A
    Am J Surg Pathol; 2021 May; 45(5):616-626. PubMed ID: 33729740
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Epithelioid hemangioendotheliomas of the liver and lung in children and adolescents.
    Hettmer S; Andrieux G; Hochrein J; Kurz P; Rössler J; Lassmann S; Werner M; von Bubnoff N; Peters C; Koscielniak E; Sparber-Sauer M; Niemeyer C; Mentzel T; Busch H; Boerries M
    Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28598585
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Epithelioid Hemangioendothelioma of the Maxillary Sinus.
    Avadhani V; Loftus PA; Meltzer D; Wang B; Tabaee A
    Head Neck Pathol; 2016 Jun; 10(2):229-32. PubMed ID: 25963905
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Multifaceted regulation and functions of YAP/TAZ in tumors (Review).
    Liu H; Du S; Lei T; Wang H; He X; Tong R; Wang Y
    Oncol Rep; 2018 Jul; 40(1):16-28. PubMed ID: 29749524
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Endothelial cell malignancies in infants, children and adolescents: Treatment results of three Cooperative Weichteilsarkom Studiengruppe (CWS) trials and one registry.
    Sparber-Sauer M; Koscielniak E; Vokuhl C; Schmid I; Bien E; Seitz G; Hallmen E; von Kalle T; Scheer M; Münter M; Bielack SS; Niggli F; Ljungman G; Fuchs J; Hettmer S; Rössler J; Klingebiel T;
    Pediatr Blood Cancer; 2020 Mar; 67(3):e28095. PubMed ID: 31814291
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hepatic
    Lotfalla MM; Folpe AL; Fritchie KJ; Greipp PT; Galliano GG; Halling KC; Mounajjed T; Torres-Mora J; Graham RP
    Case Rep Gastrointest Med; 2019; 2019():7530845. PubMed ID: 31341686
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Epithelioid Hemangioendothelioma: clinicopathologic, immunhistochemical, and molecular genetic analysis of 39 cases.
    Flucke U; Vogels RJ; de Saint Aubain Somerhausen N; Creytens DH; Riedl RG; van Gorp JM; Milne AN; Huysentruyt CJ; Verdijk MA; van Asseldonk MM; Suurmeijer AJ; Bras J; Palmedo G; Groenen PJ; Mentzel T
    Diagn Pathol; 2014 Jul; 9():131. PubMed ID: 24986479
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cysteine S-Glutathionylation Promotes Stability and Activation of the Hippo Downstream Effector Transcriptional Co-activator with PDZ-binding Motif (TAZ).
    Gandhirajan RK; Jain M; Walla B; Johnsen M; Bartram MP; Huynh Anh M; Rinschen MM; Benzing T; Schermer B
    J Biol Chem; 2016 May; 291(22):11596-607. PubMed ID: 27048650
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Recurrent WWTR1 S89W mutations and Hippo pathway deregulation in clear cell carcinomas of the cervix.
    Kim SH; Basili T; Dopeso H; Da Cruz Paula A; Bi R; Issa Bhaloo S; Pareja F; Li Q; da Silva EM; Zhu Y; Hoang T; Selenica P; Murali R; Chan E; Wu M; Derakhshan F; Maroldi A; Hanlon E; Ferreira CG; Lapa E Silva JR; Abu-Rustum NR; Zamarin D; Chandarlapaty S; Matrai C; Yoon JY; Reis-Filho JS; Park KJ; Weigelt B
    J Pathol; 2022 Aug; 257(5):635-649. PubMed ID: 35411948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.